OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity
Marwa Monier Mahmoud Refaie, Asmaa MA Bayoumi, Sahar A. Mokhemer, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 8
Marwa Monier Mahmoud Refaie, Asmaa MA Bayoumi, Sahar A. Mokhemer, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 8
Showing 8 citing articles:
SGLT2 inhibitors: how do they affect the cardiac cells
Betül Rabia Erdoğan, Ebru Arioglu‐Inan
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Betül Rabia Erdoğan, Ebru Arioglu‐Inan
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats
Shohei Asada, Kosuke Kaji, Norihisa Nishimura, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 538-538
Open Access | Times Cited: 5
Shohei Asada, Kosuke Kaji, Norihisa Nishimura, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 538-538
Open Access | Times Cited: 5
Protective effect of dapagliflozin on lipopolysaccharide-induced acute lung injury via the SIRT-1/PGC-1α pathway
Mehtap Savran, Suleyman Emre Akin, Hasan Ekrem Çamaş, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Mehtap Savran, Suleyman Emre Akin, Hasan Ekrem Çamaş, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
SGLT2 inhibitors for prevention and management of cancer treatment-related cardiovascular toxicity: a review of potential mechanisms and clinical insights
Carl Simela, John M. Walker, Arjun K. Ghosh, et al.
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
Carl Simela, John M. Walker, Arjun K. Ghosh, et al.
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
Advances in sodium-glucose transporter protein 2 inhibitors and tumors
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Bibliometric and visual analysis of SGLT2 inhibitors in cardiovascular diseases
Rongfang Pan, Yuqing He, Wan Melisandre, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Rongfang Pan, Yuqing He, Wan Melisandre, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
Linda Piras, Michela Zuccanti, Giacomo Tini, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 529-546
Open Access
Linda Piras, Michela Zuccanti, Giacomo Tini, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 529-546
Open Access
Advances in Cardio-Oncology: The Emerging Role of Sglt2 Inhibitors in Cardioprotection
T. A. Sadigova
American Journal of Biomedical and Life Sciences (2024) Vol. 12, Iss. 6, pp. 93-97
Open Access
T. A. Sadigova
American Journal of Biomedical and Life Sciences (2024) Vol. 12, Iss. 6, pp. 93-97
Open Access
